Hyperion™ International Registry Trial

NCT02220270 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2015-08-19

No results posted yet for this study

Summary

The purpose of this study is to determine the safety, performance and efficacy of the Hyperion™ Occluder Systems during treatment of ASD and PDA patients.

Conditions

  • Atrial Septal Defects
  • Patent Ductus Arteriosus

Interventions

DEVICE

ASD and PDA closure

Sponsors & Collaborators

  • Comed B.V.

    collaborator INDUSTRY
  • European Cardiovascular Research Center

    lead NETWORK

Eligibility

Min Age
1 Year
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2016-11-30
Completion
2017-08-31

Countries

  • Algeria
  • China
  • France
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02220270 on ClinicalTrials.gov